Literature DB >> 20357486

Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response.

M T Gallego1, V Iraola, M Himly, D S Robinson, C Badiola, J C García-Robaina, P Briza, J Carnés.   

Abstract

BACKGROUND: Polymerised allergenic extracts (allergoids) are commonly used in allergen immunotherapy. Clinical efficacy and safety of these extracts have been demonstrated. Recently, allergen sequences have been identified by mass spectrometry in depigmented and polymerised (Dpg-Pol) extracts. The objectives of this study were to investigate the presence of allergens in Dpg-Pol extracts of house dust mite and to analyze the immunological changes induced by these extracts in asthmatic patients enrolled in a double-blind, placebo-controlled study.
METHODS: Dpg-Pol extracts were manufactured and vaccines with a composition of 50% Dermatophagoides pteronyssinus and 50% D. farinae (100 HEPL/ml) were prepared. Allergen composition was analyzed by mass spectrometry. Patients with asthma and rhinoconjunctivitis were treated in a 1-year, double-blind, placebo-controlled, parallel-group study with 6 up-dosing and monthly maintenance injections. Specific IgE and IgG4 titres to D. pteronyssinus, Der p 1 and Der p 2 were measured in patients' sera using the CAP system and direct ELISA experiments.
RESULTS: Sequences from the major allergens Der p 1 and Der p 2 and from other allergens were identified in native and Dpg-Pol extracts. There was a statistically significant increase in specific IgG4, a decrease in the ratio of IgE/IgG4 to D. pteronyssinus and a significant increase in specific IgG4 to Der p 1 and Der p 2 in the patients allotted to active treatment.
CONCLUSIONS: The detection of allergen sequences suggests preservation of major and minor allergens in Dpg-Pol allergoids from house dust mites. Efficacy in asthma treatment and the increase in specific IgG4 seem to be associated with the presence of major allergens in Dpg-Pol allergen extracts. Copyright (c) 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20357486     DOI: 10.1159/000301580

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  14 in total

Review 1.  Standardization and Regulation of Allergen Products in the European Union.

Authors:  Julia Zimmer; Stefan Vieths; Susanne Kaul
Journal:  Curr Allergy Asthma Rep       Date:  2016-03       Impact factor: 4.806

Review 2.  Molecular approaches to allergen standardization.

Authors:  Martin D Chapman; Peter Briza
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

Review 3.  2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group.

Authors:  Michelle M Cloutier; Alan P Baptist; Kathryn V Blake; Edward G Brooks; Tyra Bryant-Stephens; Emily DiMango; Anne E Dixon; Kurtis S Elward; Tina Hartert; Jerry A Krishnan; Robert F Lemanske; Daniel R Ouellette; Wilson D Pace; Michael Schatz; Neil S Skolnik; James W Stout; Stephen J Teach; Craig A Umscheid; Colin G Walsh
Journal:  J Allergy Clin Immunol       Date:  2020-12       Impact factor: 10.793

4.  Human schistosome infection and allergic sensitisation.

Authors:  Nadine Rujeni; David W Taylor; Francisca Mutapi
Journal:  J Parasitol Res       Date:  2012-08-27

5.  Molecular fingerprinting of complex grass allergoids: size assessments reveal new insights in epitope repertoires and functional capacities.

Authors:  S Starchenka; A J Bell; J Mwange; M A Skinner; M D Heath
Journal:  World Allergy Organ J       Date:  2017-04-24       Impact factor: 4.084

6.  In vitro evidence of efficacy and safety of a polymerized cat dander extract for allergen immunotherapy.

Authors:  María Morales; Mayte Gallego; Victor Iraola; Marta Taulés; Eliandre de Oliveira; Raquel Moya; Jerónimo Carnés
Journal:  BMC Immunol       Date:  2017-02-24       Impact factor: 3.615

7.  Immunological parameters as biomarkers of response to MicroCrystalline Tyrosine-adjuvanted mite immunotherapy.

Authors:  José L Justicia; Clara Padró; Albert Roger; Francisco Moreno; Manuel J Rial; Antonio Parra; Antonio Valero; Alfons Malet; Aina Teniente; Anna Boronat; Carla Torán-Barona
Journal:  World Allergy Organ J       Date:  2021-06-06       Impact factor: 4.084

8.  Depigmented allergoids reveal new epitopes with capacity to induce IgG blocking antibodies.

Authors:  M Angeles López-Matas; Mayte Gallego; Víctor Iraola; Douglas Robinson; Jerónimo Carnés
Journal:  Biomed Res Int       Date:  2013-10-08       Impact factor: 3.411

9.  Depigmented-polymerised allergoids favour regulatory over effector T cells: enhancement by 1α, 25-dihydroxyvitamin D3.

Authors:  Zoe L Urry; David F Richards; Cheryl Black; Maria Morales; Jerónimo Carnés; Catherine M Hawrylowicz; Douglas S Robinson
Journal:  BMC Immunol       Date:  2014-05-29       Impact factor: 3.615

Review 10.  Safety of engineered allergen-specific immunotherapy vaccines.

Authors:  Margarete Focke-Tejkl; Rudolf Valenta
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.